IOVANCE BIOTHERAPEUTICS INC (IOVA)

US4622601007 - Common Stock

12.88  +0.38 (+3.04%)

After market: 12.87 -0.01 (-0.08%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
1.19M0.000.000.000.00
Cost Of Goods
10.76MN/AN/AN/AN/A
Gross Profit
-9.57MN/AN/AN/AN/A
Operating Expenses
450.99M398.88M342.70M261.94M206.87M
Research and Development
344.08M294.78M259.04M201.73M166.02M
Selling, General, and Administrative Expenses
106.92M104.10M83.66M60.21M40.85M
Operating Income
-460.56M-398.88M-342.70M-261.94M-206.87M
Interest Income/Expense
13.04M2.99M450.00K2.36M9.32M
Income Before Taxes
-447.52M-395.89M-342.25M-259.58M-197.56M
Income Tax
-3.48MN/AN/AN/AN/A
Net Income
-444.04M-395.89M-342.25M-259.58M-197.56M
EBITDA
-439.14M-389.57M-339.59M-260.80M-205.70M
 
Per Share Data
EPS Diluted Total Ops
-1.89-2.49-2.23-1.88-1.59
Non GAAP EPS
-1.88-2.48-2.22-1.89-1.58
 
Statistics
Gross Profit Margin
-804.54%N/AN/AN/AN/A
Profit Margin
-37345.42%N/AN/AN/AN/A
Operating Profit Margin
-38734.99%N/AN/AN/AN/A

All data in USD

Charts